Arkolith/Insider Trading/TXG/Form 4

Saxonov Serge

Chief Executive Officer, Director10x Genomics, Inc. (TXG) · full profile →Form 4 · filed Mar 25, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$289K
Net Open-Market Flow
-$289K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 24, 2026Sell(S)5K$19.52$98K1.2M
Mar 23, 2026Sell(S)10K$19.13$191K1.2M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001610717-26-000134) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML